EI
BEAM icon

Ellevest Inc’s Beam Therapeutics BEAM Stock Holding History

Ellevest Inc’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16
Closed -$490 – 503
2023
Q1 		$490 Hold
16
– – ﹤0.01% 1679
2022
Q4 		$626 Sell
16
-8
-33% -$358 ﹤0.01% 1588
2022
Q3 		$1K Buy
24
+15
+167% +$856 ﹤0.01% 1424
2022
Q2 		$0 Buy
9
+2
+29% +$79 ﹤0.01% 1403
2022
Q1 		$0 Sell
7
-5
-42% -$328 ﹤0.01% 1421
2021
Q4 		$1K Sell
12
-3
-20% -$257 ﹤0.01% 1245
2021
Q3 		$1K Buy
15
+2
+15% +$201 ﹤0.01% 1231
2021
Q2 		$2K Buy
+13
New +$1.04K ﹤0.01% 1009

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ellevest Inc's BEAM Position: Q2 2023 in Review

Ellevest Inc sold out of Beam Therapeutics (BEAM) in Q2 2023, closing a stake of 16 shares — an estimated $490 sold.

Ellevest Inc first reported a position in BEAM in Q2 2021 and held it in 8 quarters. The position peaked at $2K in Q2 2021. 193 funds tracked by Wall St. Rank hold BEAM as of Q2 2023.

  • Ellevest Inc reported no remaining Beam Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 16 Beam Therapeutics shares in Q2 2023, an estimated $490.
  • Ellevest Inc first reported a position in Beam Therapeutics in Q2 2021 and held it in 8 quarters.
  • Ellevest Inc's Beam Therapeutics position peaked at $2K in Q2 2021.
  • 193 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.